Ocular indicators of Alzheimer's: exploring disease in the retina

被引:190
作者
Hart, Nadav J. [1 ]
Koronyo, Yosef [1 ]
Black, Keith L. [1 ]
Koronyo-Hamaoui, Maya [1 ,2 ]
机构
[1] Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Res Inst, Dept Neurosurg, 127 S San Vicente Blvd, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Dept Biomed Sci, 110 George Burns Rd, Los Angeles, CA 90048 USA
关键词
Alzheimer's disease; Amyloid-beta; Tauopathy; Retinal biomarkers; Ocular abnormalities; Neurodegenerative disease; NERVE-FIBER LAYER; MILD COGNITIVE IMPAIRMENT; AMYLOID PRECURSOR PROTEIN; TRANSGENIC MOUSE MODEL; POSITRON-EMISSION-TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY; GANGLION-CELLS; MACULAR DEGENERATION; FUNCTIONAL IMPAIRMENT; PARKINSONS-DISEASE;
D O I
10.1007/s00401-016-1613-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Although historically perceived as a disorder confined to the brain, our understanding of Alzheimer's disease (AD) has expanded to include extra-cerebral manifestation, with mounting evidence of abnormalities in the eye. Among ocular tissues, the retina, a developmental outgrowth of the brain, is marked by an array of pathologies in patients suffering from AD, including nerve fiber layer thinning, degeneration of retinal ganglion cells, and changes to vascular parameters. While the hallmark pathological signs of AD, amyloid beta-protein (A beta) plaques and neurofibrillary tangles (NFT) comprising hyperphosphorylated tau (pTau) protein, have long been described in the brain, identification of these characteristic biomarkers in the retina has only recently been reported. In particular, A beta deposits were discovered in post-mortem retinas of advanced and early stage cases of AD, in stark contrast to non-AD controls. Subsequent studies have reported elevated A beta(42/40) peptides, morphologically diverse A beta plaques, and pTau in the retina. In line with the above findings, animal model studies have reported retinal A beta deposits and tauopathy, often correlated with local inflammation, retinal ganglion cell degeneration, and functional deficits. This review highlights the converging evidence that AD manifests in the eye, especially in the retina, which can be imaged directly and non-invasively. Visual dysfunction in AD patients, traditionally attributed to well-documented cerebral pathology, can now be reexamined as a direct outcome of retinal abnormalities. As we continue to study the disease in the brain, the emerging field of ocular AD warrants further investigation of how the retina may faithfully reflect the neurological disease. Indeed, detection of retinal AD pathology, particularly the early presenting amyloid biomarkers, using advanced high-resolution imaging techniques may allow large-scale screening and monitoring of at-risk populations.
引用
收藏
页码:767 / 787
页数:21
相关论文
共 186 条
  • [1] Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease
    Alexandrov, Peter N.
    Pogue, Aileen
    Bhattacharjee, Surjyadipta
    Lukiw, Walter J.
    [J]. NEUROREPORT, 2011, 22 (12) : 623 - 627
  • [2] Drusen maculopathy: a risk factor for visual deterioration
    Algvere, Peep V.
    Kvanta, Anders
    Seregard, Stefan
    [J]. ACTA OPHTHALMOLOGICA, 2016, 94 (05) : 427 - 433
  • [3] Optic Disc and Optic Cup Segmentation Methodologies for Glaucoma Image Detection: A Survey
    Almazroa, Ahmed
    Burman, Ritambhar
    Raahemifar, Kaamran
    Lakshminarayanan, Vasudevan
    [J]. JOURNAL OF OPHTHALMOLOGY, 2015, 2015
  • [4] Anti-Aggregating Effect of the Naturally Occurring Dipeptide Carnosine on Aβ1-42 Fibril Formation
    Aloisi, Alessandra
    Barca, Amilcare
    Romano, Alessandro
    Guerrieri, Sara
    Storelli, Carlo
    Rinaldi, Rosaria
    Verri, Tiziano
    [J]. PLOS ONE, 2013, 8 (07):
  • [5] [Anonymous], 2014, INT J OPHTHALMIC PAT
  • [6] VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina
    Antes, Ran
    Salomon-Zimri, Shiran
    Beck, Susanne C.
    Garrido, Marina Garcia
    Livnat, Tami
    Maharshak, Idit
    Kadar, Tamar
    Seeliger, Mathias
    Weinberger, Dov
    Michaelson, Daniel M.
    [J]. CURRENT ALZHEIMER RESEARCH, 2015, 12 (04) : 323 - 334
  • [7] ApoE4 Induces Synaptic and ERG Impairments in the Retina of Young Targeted Replacement ApoE4 Mice
    Antes, Ran
    Ezra-Elia, Raaya
    Weinberger, Dov
    Solomon, Arie
    Ofri, Ron
    Michaelson, Daniel M.
    [J]. PLOS ONE, 2013, 8 (05):
  • [8] The retina in Parkinsons disease
    Archibald, Neil K.
    Clarke, Michael P.
    Mosimann, Urs P.
    Burn, David J.
    [J]. BRAIN, 2009, 132 : 1128 - 1145
  • [9] Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer's disease
    Ardiles, Alvaro O.
    Tapia-Rojas, Cheril C.
    Mandal, Madhuchhanda
    Alexandre, Frederic
    Kirkwood, Alfredo
    Inestrosa, Nibaldo C.
    Palacios, Adrian G.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (34) : 13835 - 13840
  • [10] Oculo-visual changes and clinical considerations affecting older patients with dementia
    Armstrong, Richard
    Kergoat, Helene
    [J]. OPHTHALMIC AND PHYSIOLOGICAL OPTICS, 2015, 35 (04) : 352 - 376